Science | ABNewswire

Herpes Zoster Treatment Market Size in the 7MM is projected to increase at a significantly CAGR by 2036, estimates DelveInsight

DelveInsight’s “Herpes Zoster Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Herpes Zoster, historical and forecasted epidemiology as well as the Herpes Zoster market trends in the United States, EU5 (Germany, Spain, Italy, France, and … Continue reading →

1752vc Launches New Push for Accelerate Program, Invites AI Startups to Apply

Santa Monica, CA – April 7, 2026 – 1752vc today announced a major expansion of its flagship accelerator, Accelerate, with a renewed focus on backing and scaling high-growth AI companies. Following its recognition as one of the Best Startup Programs of … Continue reading →

GD&T Online Course by Excedify Adopted by 150+ Companies Worldwide

GD&T online course thumbnail Discover the GD&T online course trusted by 150+ companies, including Yamaha. Replace outdated training with practical, application-driven GD&T training online. The GD&T online course developed by Excedify is now being used by more than 150 companies … Continue reading →

Opioid Use Disorder Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Opioid Use Disorder Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Opioid Use Disorder pipeline landscape. It covers the Opioid Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Knee Osteoarthritis Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Knee Osteoarthritis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Knee Osteoarthritis pipeline landscape. It covers the Knee Osteoarthritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

BK Virus Infection Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “BK Virus Infection Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in BK Virus Infection pipeline landscape. It covers the BK Virus Infection pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Postpartum Depression Clinical Trial Pipeline Shows Potential with Active Contributions from 10+ Key Companies | DelveInsight

DelveInsight’s, “Postpartum Depression Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Postpartum Depression pipeline landscape. It covers the Postpartum Depression pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Liver Fibrosis Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Liver Fibrosis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Liver Fibrosis pipeline landscape. It covers the Liver Fibrosis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Metastatic Hormone Refractory Prostate Cancer Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Metastatic Hormone Refractory Prostate Cancer Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Metastatic Hormone Refractory Prostate Cancer pipeline landscape. It covers the Metastatic Hormone Refractory Prostate Cancer Pipeline drug profiles, … Continue reading →

Alibaba Launches Wan 2.7: Breakthrough AI Image & Video Generation Model with Thinking Mode

Wan 2.7-generated image demonstrating hyper-realistic character details and precise color control Alibaba’s Tongyi Lab has officially released Wan 2.7, the latest major upgrade to its Wan (Wanxiang) AI series. Featuring innovative “Thinking Mode”, hyper-realistic character consistency, precise color control, superior … Continue reading →

Monday - April 13, 2026

Category Archives: Science